GRDNGuardian Pharmacy Services, Inc.

$41.24+62% 1Y

What is the market doing?

Mixed

No clear lean: nothing decisive, though in an uptrend.

1 good, 1 neutral, 1 without data
TrendUptrendderived · Oct 9, 2026

In an uptrend, above its rising 50- and 200-day averages. Price is +12% vs its 200-day average.

Short interest4.0% of sharesFINRA · Sep 15, 2026

Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 20% since the previous count, down from 5.4% of shares outstanding three months ago.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnbetter than 86% of the market
vs 200-day avgbetter than 77% of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How GRDN is trading

Guardian Pharmacy Services, Inc. is +62% over the past year while the S&P 500 is +18%: 44 points ahead of the market.

+62%

1-year return · S&P 500 +18%

vs 200-day average
+12%

vs 200-day average · a clear uptrend

RSI (14)
34

RSI (14) · neutral

Below its 52-week high
14%

Below its 52-week high

Sep 26, 2024$16.00 – $48.01 · dashed line: 200-day averageOct 9, 2026
Details›
Last close2026-10-09
$41.24
1 monthS&P 500 +2.7%
−6.0%
1 yearS&P 500 +18%
+62%
vs 50-day average$41.04
+0.48%
52-week high
$48.01
52-week low
$23.41
Annualised volatility
47%
Calendar-year price return
YearReturn
2026 (year to date)+37%
2025+49%
Average return by calendar month, 2024–2026
MonthYearsPositiveAverage
Jan22 of 2+6.5%
Feb21 of 2−0.68%
Mar22 of 2+9.3%
Apr21 of 2+8.1%
May21 of 2−5.5%
Jun22 of 2+0.51%
Jul21 of 2+2.8%
Aug21 of 2+7.6%
Sep21 of 2+4.6%
Oct33 of 3+4.9%
Nov22 of 2+22%
Dec21 of 2−8.0%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.